Literature DB >> 7876608

Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit.

R W Haley1, N B Cushion, F C Tenover, T L Bannerman, D Dryer, J Ross, P J Sánchez, J D Siegel.   

Abstract

To control infections with endemic methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit (NICU), triple dye was applied to the umbilical cords of infants in the intermediate-care but not the intensive-care area. The rate of MRSA infection, adjusted for time and intensity of care, decreased in the intermediate-care area (rate ratio, 0.35; 95% confidence interval [CI], 0.14-0.87; P < .01) but not in the intensive-care area (rate ratio, 0.92; 95% CI, 0.41-2.24; P = .48). After 22 months, the rate increased in both areas (Mantel-Haenszel rate ratio, 1.7; 95% CI, 1.0-2.8; P < .05) after overcrowding and understaffing increased. After temporary reduction of overcrowding and understaffing, extension of triple dye use to the intensive-care area and dedication of an infection control nurse to the NICU, MRSA colonization and infection rates decreased to near zero in both areas (infection rate ratios, 0.09 and 0.11, respectively; P < .005). The endemic MRSA strain, identified by pulsed-field gel electrophoresis, was eradicated.

Entities:  

Mesh:

Year:  1995        PMID: 7876608     DOI: 10.1093/infdis/171.3.614

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Hand Hygiene Revisited: Lessons from the Past and Present.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs.

Authors:  D J Austin; M J Bonten; R A Weinstein; S Slaughter; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Molecular characteristics of nosocomial and Native American community-associated methicillin-resistant Staphylococcus aureus clones from rural Wisconsin.

Authors:  Sanjay K Shukla; Mary E Stemper; Srinivas V Ramaswamy; Jennifer M Conradt; Robert Reich; Edward A Graviss; Kurt D Reed
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

5.  The impact of health care restructuring on nosocomial infections and transmission of antimicrobial resistant organisms.

Authors:  J Conly; L Johnston
Journal:  Can J Infect Dis       Date:  2001-09

6.  Clinical evaluation of the DiversiLab microbial typing system using repetitive-sequence-based PCR for characterization of Staphylococcus aureus strains.

Authors:  Cheryl K Shutt; June I Pounder; Sam R Page; Barbara J Schaecher; Gail L Woods
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Essentials of paediatric infection control.

Authors:  D L Moore
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

Review 9.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

10.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards.

Authors:  Ken Kikuchi; Naoto Takahashi; Chuncheng Piao; Kyoichi Totsuka; Hiroshi Nishida; Takehiko Uchiyama
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.